Pyrimidine compound as jak kinase inhibitor
AssigneeTheravance Biopharma R&D IP, LLC
InventorsJENNIFER KOZAK, RYAN HUDSON, ROBERT MURRAY MCKINNELL, GARY E.L. BRANDT
Life of this patent
Estimating the term…
Abstract
The invention provides a compound of formula (I): or a pharmaceutically-acceptable salt thereof, that is an inhibitor of JAK kinases. The invention also provides pharmaceutical compositions comprising such compound, a crystalline form, methods of using such compound to treat inflammatory skin diseases and other diseases, and processes and intermediates useful for preparing such compound.
Claims20
1-32. (canceled)
A method of treating atopic dermatitis in a human in need thereof comprising administering to the human a therapeutically effective amount of a compound of formula (I):
- or a pharmaceutically-acceptable salt thereof.
Dependencies are inferred from the claim text.